Effects of lapatinib and trastuzumab on vascular endothelial growth factor in experimental corneal neovascularization

Publisher： John Wiley & Sons Inc

E-ISSN： 1442-9071|43|5|449-457

ISSN： 1442-6404

Source： CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol.43, Iss.5, 2015-07, pp. : 449-457

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Interaction between the Renin-Angiotensin System and Vascular Endothelial Growth Factor in the Pathogenesis of Retinal Neovascularization in Diabetes

By  

Journal of Vascular Research, Vol. 38, Iss. 6, 2001-12 ,pp. : 527-535

Karger

Access to resources Recommend Favorite

Rofecoxib inhibits retinal neovascularization via down regulation of cyclooxygenase‐2 and vascular endothelial growth factor expression

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 43, Iss. 5, 2015-07 ,pp. : 458-465

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Partially Inhibits the Trastuzumab-Mediated Antibody-Dependent Cellular Cytotoxicity of Human Monocytes

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 172-180

Karger

Access to resources Recommend Favorite

Differential Effects of Vascular Endothelial Growth Factor-C and Placental Growth Factor-1 on the Hydraulic Conductivity of Frog Mesenteric Capillaries

By  

Journal of Vascular Research, Vol. 38, Iss. 2, 2001-04 ,pp. : 176-186

Karger

Access to resources Recommend Favorite

Vascular endothelial cadherin and vascular endothelial growth factor in periodontitis and smoking

By  

ORAL DISEASES, Vol. 21, Iss. 2, 2015-03 ,pp. : 263-269

John Wiley & Sons Inc

Access to resources Recommend Favorite